European Market-Entry Strategy for Biopharma Companies
World Orphan Drug Alliance (WODA) is a global alliance of regional full-service distributors for orphan drugs. EffRx has combined forces together with twelve other orphan drugs experts – Medis, Vector Pharma, OrphanDC, Orpharm, Veld Pharma, Arrotex Pharmaceuticals, Celystra Pharma, Healthmount,Path Pharma,CTC, Nxera and Innovative Medicines Group – to reach rare disease patients in complex and often overlooked countries.
WODA covers 158 countries in the following regions:
Central and Eastern Europe (Medis)
Latin America (Innovative Medicines Group)
Middle East, North Africa & Turkey (Vector Pharma)
Russia & the CIS region (Orpharm)
Switzerland (EffRx Pharmaceuticals
Sub‑Saharan Africa (Veld Pharma)
Australia & New Zealand (Arrotex Pharmaceuticals)
Canada (Celystra Pharma
Greater China (Healthmount
Greece, Cyprus & Malta (Path Pharma
Israel (CTS)
Japan & South Korea (Nxera Pharma)
WODA provides pharmaceutical & biotech companies with a rare disease portfolio:
Access to 210 million potential rare disease patients